Results 211 to 220 of about 2,661,570 (257)
Some of the next articles are maybe not open access.

Progress in Alzheimer’s disease

Journal of Neurology, 2011
After more than one century from Alois Alzheimer and Gaetano Perusini's first report, progress has been made in understanding the pathogenic steps of Alzheimer's disease (AD), as well as in its early diagnosis. This review discusses recent findings leading to the formulation of novel criteria for diagnosis of the disease even in a preclinical phase, by
D. Galimberti, E. Scarpini
openaire   +4 more sources

The Progression of Renal Disease

New England Journal of Medicine, 1988
The diversity of its causes, the unpredictability of its clinical course, and our expanding knowledge of the conditions that may exacerbate or retard its progression suggest that glomerular sclerosis cannot be attributed to a single aberration in glomerular physiology.
Saulo Klahr   +5 more
openaire   +4 more sources

Progress in moyamoya disease

Neurosurgical Review, 2018
Moyamoya disease is characterized by progressive stenosis or occlusion of the intracranial portion of the internal carotid artery and their proximal branches, resulting in ischemic or hemorrhagic stroke with high rate of disability and even death. So far, available treatment strategies are quite limited, and novel intervention method is being explored.
Shuling Shang   +7 more
openaire   +3 more sources

Inflammation and disease progression

Cancer and Metastasis Reviews, 2006
Inflammation is a physiological response to a foreign organism such as bacteria, dust particles, and viruses. Recent studies have enlightened the role of inflammation in the progression of a variety of diseases such as cancer, atherosclerosis, asthma, and psoriasis.
Sriram Krishnamoorthy, Kenneth V. Honn
openaire   +3 more sources

Progression of Scleral Disease

Ophthalmology, 1991
The clinical features of 290 patients with scleral inflammation were reviewed to determine whether a classification based on the anatomical site and clinical appearance of the disease at presentation reflected its natural history. The authors' results confirm that the majority of patients remain in the same clinical category throughout the course of ...
Stephen J. Tuft, Peter G. Watson
openaire   +3 more sources

Periodontal Disease Progression

Journal of Periodontology, 2000
Background: The objective of this investigation is to use noninvasive, state‐of‐the‐art, diagnostic techniques to measure periodontal disease progression and model periodontal disease activity over time. In this investigation, digital subtraction radiography and an electronic controlled force periodontal probe capable of attachment level measurement ...
Michael S. Reddy   +4 more
openaire   +3 more sources

Progressive Conduction Diseases

Cardiac Electrophysiology Clinics, 2010
Progressive cardiac conduction disease (PCCD), a source of considerable morbidity, comprises a heterogeneous group of conditions resulting from genetic predisposition, environmental modifiers, and other physiologic determinants, including aging. The genetic factors include numerous mutations and variants within the cardiac sodium channel gene, SCN5A ...
Christopher L.-H. Huang   +2 more
openaire   +3 more sources

Diseases of medical progress

Clinical Pharmacology & Therapeutics, 1956
Because of its well‐founded and penetrating significance, the publication of “Diseases of Medical Progress” in the New England Journal of Medicine in 1956 attracted a great deal of attention in well‐informed medical circles. A monograph which surveyed the growing and increasingly serious subject was published by the author in 1959 (Charles C Thomas ...
openaire   +4 more sources

Progress in Parkinson’s disease

European Journal of Neurology, 2003
The past few years have seen important advances in our understanding of the causes of Parkinson’s disease (PD) and in our ability to optimize the symptomatic management of the motor features that characterize this disorder. This supplement reviews progress in several important areas of PD and encompasses some of the basic science that underlies current
openaire   +4 more sources

Disease progression and neuroscience

Journal of Pharmacokinetics and Pharmacodynamics, 2013
The concepts of disease progression are discussed in the context of neurological disorders. The importance of understanding the time course of the response to inactive (placebo) treatment is discussed. Disease progression and response to placebo treatment both need to be considered before drug effects can be reliably identified.
openaire   +3 more sources

Home - About - Disclaimer - Privacy